×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INBX – inhibrx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INBX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/2
04:13 pm
inbx
Inhibrx Announces Participation in Upcoming Scientific Conference [Yahoo! Finance]
Medium
Report
Inhibrx Announces Participation in Upcoming Scientific Conference [Yahoo! Finance]
3/2
04:00 pm
inbx
Inhibrx Announces Participation in Upcoming Scientific Conference
Medium
Report
Inhibrx Announces Participation in Upcoming Scientific Conference
2/26
05:47 pm
inbx
Chondrosarcoma Treatment Market Forecasts Robust Growth During the Forecast Period (2026-2036) as Oncology Pipeline Strengthens | DelveInsight [Yahoo! Finance]
Medium
Report
Chondrosarcoma Treatment Market Forecasts Robust Growth During the Forecast Period (2026-2036) as Oncology Pipeline Strengthens | DelveInsight [Yahoo! Finance]
1/24
05:08 am
inbx
Inhibrx Biosciences (NASDAQ:INBX) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Inhibrx Biosciences (NASDAQ:INBX) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
1/13
03:17 pm
inbx
Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too [Seeking Alpha]
Low
Report
Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too [Seeking Alpha]
12/28
10:27 am
inbx
Inhibrx Advances Key Oncology Programs Toward Multiple 2026 Data Readouts [Yahoo! Finance]
Low
Report
Inhibrx Advances Key Oncology Programs Toward Multiple 2026 Data Readouts [Yahoo! Finance]
12/16
05:36 pm
inbx
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program [Yahoo! Finance]
Low
Report
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program [Yahoo! Finance]
12/16
05:00 pm
inbx
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program
Low
Report
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/23
09:00 am
inbx
Form 8-K Inhibrx Biosciences, For: Feb 23
Low
Report
Form 8-K Inhibrx Biosciences, For: Feb 23
2/17
04:28 pm
inbx
Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: VIKING GLOBAL INVESTORS LP
Medium
Report
Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: VIKING GLOBAL INVESTORS LP
2/11
01:34 pm
inbx
Form SCHEDULE 13G Inhibrx Biosciences, Filed by: MORGAN STANLEY
Low
Report
Form SCHEDULE 13G Inhibrx Biosciences, Filed by: MORGAN STANLEY
1/21
12:32 pm
inbx
Form SCHEDULE 13G Inhibrx Biosciences, Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G Inhibrx Biosciences, Filed by: BlackRock, Inc.
12/16
05:00 pm
inbx
Form 8-K Inhibrx Biosciences, For: Dec 16
Low
Report
Form 8-K Inhibrx Biosciences, For: Dec 16
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: